Strand Therapeutics
PrivateLast Round
Series B
Mar 17, 2026
Est. Valuation
$550M
Total Funding Raised
$256M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Strand Therapeutics is a biotechnology company focused on developing gene therapies utilizing synthetic biology to create immunotherapies that enhance the immune system's ability to combat cancer by producing targeted cancer-killing proteins.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Strand Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Strand Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 17, 2026 | ||||
| Series B | Aug 7, 2025 | ||||
| Series A Extension | Nov 28, 2022 | ||||
| Series A | Jun 23, 2021 | ||||
| Seed | Jun 4, 2019 |
Key People
Founding team and executive leadership
Strand Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series A |
| ICONIQ Capital | Series B |
| Camford Capital | Series A |
| Playground Global | Series B, Series A Extension, Series A, Seed |
| LG Technology Ventures | Series B |
| ANRI株式会社 | Series B, Seed, Series A |
| JIC Venture Growth Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 1, 2026
Lead program STX-001 now in Phase 1 trial for solid tumors.
- Aug 23, 2025
Dr. Jason J. Luke appointed as new Chief Medical Officer.
Strand Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Strand Therapeutics's valuation, stock price, and market status.